Five success pillars — your JCA evidence-generation checklist From 12th January 2025, the Eu...
Read moreThe recent Medicines and Healthcare products Regulatory Agency (MHRA) approval of the Alzheimer’s ...
Read moreThe Joint Clinical Assessment (JCA), a core feature of the Regulation (EU) 2021/2282, aims to stream...
Read moreDecisions regarding National Institute for Health and Care Excellence (NICE) appraisals are not made...
Read moreThe National Institute of Health and Care Excellence (NICE) has published several updates and releas...
Read moreMost pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...
Read moreSecuring a positive recommendation from the National Institute for Health and Care Excellence (NICE)...
Read moreWhen bringing a new health technology to market in England, pharmaceutical and biotech companies mus...
Read moreThe increasing complexity of bringing innovative therapies to market across various jurisdictions pr...
Read moreWith the implementation of the EU HTA (Regulation (EU) 2025/117) and ongoing adaptation of methods u...
Read more